IBDEI0QU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11979,2)
 ;;=^5007642
 ;;^UTILITY(U,$J,358.3,11980,0)
 ;;=I70.363^^80^768^13
 ;;^UTILITY(U,$J,358.3,11980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11980,1,3,0)
 ;;=3^Athscl of Unspec Bypass,Bilateral Legs w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11980,1,4,0)
 ;;=4^I70.363
 ;;^UTILITY(U,$J,358.3,11980,2)
 ;;=^5007643
 ;;^UTILITY(U,$J,358.3,11981,0)
 ;;=E10.52^^80^768^16
 ;;^UTILITY(U,$J,358.3,11981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11981,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Prph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11981,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,11981,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,11982,0)
 ;;=E11.52^^80^768^17
 ;;^UTILITY(U,$J,358.3,11982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11982,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Prph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11982,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,11982,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,11983,0)
 ;;=R13.19^^80^769^40
 ;;^UTILITY(U,$J,358.3,11983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11983,1,3,0)
 ;;=3^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,11983,1,4,0)
 ;;=4^R13.19
 ;;^UTILITY(U,$J,358.3,11983,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,11984,0)
 ;;=R15.9^^80^769^47
 ;;^UTILITY(U,$J,358.3,11984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11984,1,3,0)
 ;;=3^Full Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,11984,1,4,0)
 ;;=4^R15.9
 ;;^UTILITY(U,$J,358.3,11984,2)
 ;;=^5019247
 ;;^UTILITY(U,$J,358.3,11985,0)
 ;;=D50.0^^80^769^58
 ;;^UTILITY(U,$J,358.3,11985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11985,1,3,0)
 ;;=3^Iron Deficiency Anemia d/t Blood Loss
 ;;^UTILITY(U,$J,358.3,11985,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,11985,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,11986,0)
 ;;=D50.9^^80^769^59
 ;;^UTILITY(U,$J,358.3,11986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11986,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,11986,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,11986,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,11987,0)
 ;;=D62.^^80^769^5
 ;;^UTILITY(U,$J,358.3,11987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11987,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,11987,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,11987,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,11988,0)
 ;;=D64.9^^80^769^13
 ;;^UTILITY(U,$J,358.3,11988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11988,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,11988,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,11988,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,11989,0)
 ;;=E10.9^^80^769^31
 ;;^UTILITY(U,$J,358.3,11989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11989,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,11989,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,11989,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,11990,0)
 ;;=E11.9^^80^769^32
 ;;^UTILITY(U,$J,358.3,11990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11990,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,11990,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,11990,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,11991,0)
 ;;=E13.9^^80^769^33
 ;;^UTILITY(U,$J,358.3,11991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11991,1,3,0)
 ;;=3^Diabetes w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,11991,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,11991,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,11992,0)
 ;;=F03.90^^80^769^30
